Document is current
Any future updates will be listed below
-
Authors
Bosch, Oliver G.
Halm, Simon
Seifritz, Erich
- License Information
-
More Information
Article History
Received: 23 December 2021
Accepted: 9 June 2022
First Online: 5 July 2022
Declarations
:
: Dr. Bosch has received honoraria as a lecturer from Janssen-Cilag. He declares no further conflict of interest. Dr. Halm declares no conflict of interest. Prof. Dr. Seifritz has received honoraria as a lecturer from Janssen-Cilag. He declares no further conflict of interest. Janssen-Cilag is manufacturing and marketing the esketamine nasal spray Spravato for the treatment of therapy-resistant depression.
: Not applicable.
: Not applicable.
: Dr. Bosch has received honoraria as a lecturer from Janssen-Cilag. He declares no further conflict of interest. Dr. Halm declares no conflict of interest. Prof. Dr. Seifritz has received honoraria as a lecturer from Janssen-Cilag. He declares no further conflict of interest.
